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Background: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and often presents with heart failure 
symptoms such as exertional dyspnea. A subaortic membrane is a rare cause of symptoms that can mimic HCM. Distinguishing between 
these two entities is crucial, as treatment differs.
case:  A 34-year-old male was referred for progressive angina and New York Heart Association class III exertional dyspnea despite 
medical therapy, presumed secondary to HCM. His past medical history was significant for atrial fibrillation and primary prevention ICD 
implantation. There was no family history of HCM. Transthoracic echocardiography (TTE) demonstrated asymmetric left ventricular 
hypertrophy (basal septum 19 mm). Dynamic left ventricular outflow tract (LVOT) obstruction was absent at rest, with Valsalva, and with 
amyl nitrite provocation. However, the LVOT velocity (by CW Doppler) was increased with each (2.3 meters/second at rest; 2.8 meters/
second with Valsalva; 2.8 meters/second with amyl nitrite). Minimal systolic anterior motion of the mitral valve was demonstrated.
decision Making:  Given suspicion of a fixed obstruction, a repeat focused TTE was performed and revealed a subaortic membrane. 
Coronary computed tomography angiography was negative for coronary artery disease and confirmed asymmetric septal hypertrophy 
with a subaortic membrane. Cardiac catheterization revealed both fixed and dynamic LVOT obstruction with an increase in gradient 
from 22 mmHg at rest to 50 mmHg after isoproterenol infusion. Surgical resection of the subaortic membrane and septal myectomy 
were performed. Post-operative TTE revealed no remaining significant LVOT obstruction. The patient tolerated the procedure well with 
subsequent symptomatic relief.
conclusion:  This case highlights the importance of elucidating the underlying cause of heart failure in patients with structural heart 
disease. This patient had been initially misdiagnosed as having HCM and additional medical therapies or alcohol septal ablation would 
have been ineffective for symptom control. Recognition of mimics of hypertrophic cardiomyopathy is an important aspect of therapeutic 
decision making.
